Report Detail

Pharma & Healthcare Global Natural Killer (NK) Cell Therapeutics Market Research Report 2019

  • RnM3041584
  • |
  • 28 February, 2019
  • |
  • Global
  • |
  • 98 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.

The global Natural Killer (NK) Cell Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Natural Killer (NK) Cell Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Natural Killer (NK) Cell Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Chipscreen Biosciences (China)
Affimed NV (Netherlands)
Altor BioScience Corporation (USA)
Innate Pharma SA (France)
Takeda Pharmaceutical (Japan)
Sorrento Therapeutics Inc. (USA)
NantKwest Inc. (USA)
Bristol-Myers Squibb (USA)
NKT Therapeutics (USA)

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Mogamulizumab
Lorvotuzumab Mertansine
Others

Segment by Application
Cancer
Cardiovascular Diseases
Others


Table of Contents

    Executive Summary

      1 Natural Killer (NK) Cell Therapeutics Market Overview

      • 1.1 Product Overview and Scope of Natural Killer (NK) Cell Therapeutics
      • 1.2 Natural Killer (NK) Cell Therapeutics Segment by Type
        • 1.2.1 Global Natural Killer (NK) Cell Therapeutics Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Mogamulizumab
        • 1.2.3 Lorvotuzumab Mertansine
        • 1.2.4 Others
      • 1.3 Natural Killer (NK) Cell Therapeutics Segment by Application
        • 1.3.1 Natural Killer (NK) Cell Therapeutics Consumption Comparison by Application (2014-2025)
        • 1.3.2 Cancer
        • 1.3.3 Cardiovascular Diseases
        • 1.3.4 Others
      • 1.4 Global Natural Killer (NK) Cell Therapeutics Market by Region
        • 1.4.1 Global Natural Killer (NK) Cell Therapeutics Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Natural Killer (NK) Cell Therapeutics Market Size
        • 1.5.1 Global Natural Killer (NK) Cell Therapeutics Revenue (2014-2025)
        • 1.5.2 Global Natural Killer (NK) Cell Therapeutics Production (2014-2025)

      2 Global Natural Killer (NK) Cell Therapeutics Market Competition by Manufacturers

      • 2.1 Global Natural Killer (NK) Cell Therapeutics Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Natural Killer (NK) Cell Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Natural Killer (NK) Cell Therapeutics Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Natural Killer (NK) Cell Therapeutics Production Sites, Area Served, Product Types
      • 2.5 Natural Killer (NK) Cell Therapeutics Market Competitive Situation and Trends
        • 2.5.1 Natural Killer (NK) Cell Therapeutics Market Concentration Rate
        • 2.5.2 Natural Killer (NK) Cell Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Natural Killer (NK) Cell Therapeutics Production Market Share by Regions

      • 3.1 Global Natural Killer (NK) Cell Therapeutics Production Market Share by Regions
      • 3.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Natural Killer (NK) Cell Therapeutics Production
        • 3.4.1 North America Natural Killer (NK) Cell Therapeutics Production Growth Rate (2014-2019)
        • 3.4.2 North America Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Natural Killer (NK) Cell Therapeutics Production
        • 3.5.1 Europe Natural Killer (NK) Cell Therapeutics Production Growth Rate (2014-2019)
        • 3.5.2 Europe Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Natural Killer (NK) Cell Therapeutics Production (2014-2019)
        • 3.6.1 China Natural Killer (NK) Cell Therapeutics Production Growth Rate (2014-2019)
        • 3.6.2 China Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Natural Killer (NK) Cell Therapeutics Production (2014-2019)
        • 3.7.1 Japan Natural Killer (NK) Cell Therapeutics Production Growth Rate (2014-2019)
        • 3.7.2 Japan Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Natural Killer (NK) Cell Therapeutics Consumption by Regions

      • 4.1 Global Natural Killer (NK) Cell Therapeutics Consumption by Regions
      • 4.2 North America Natural Killer (NK) Cell Therapeutics Consumption (2014-2019)
      • 4.3 Europe Natural Killer (NK) Cell Therapeutics Consumption (2014-2019)
      • 4.4 China Natural Killer (NK) Cell Therapeutics Consumption (2014-2019)
      • 4.5 Japan Natural Killer (NK) Cell Therapeutics Consumption (2014-2019)

      5 Global Natural Killer (NK) Cell Therapeutics Production, Revenue, Price Trend by Type

      • 5.1 Global Natural Killer (NK) Cell Therapeutics Production Market Share by Type (2014-2019)
      • 5.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2014-2019)
      • 5.3 Global Natural Killer (NK) Cell Therapeutics Price by Type (2014-2019)
      • 5.4 Global Natural Killer (NK) Cell Therapeutics Production Growth by Type (2014-2019)

      6 Global Natural Killer (NK) Cell Therapeutics Market Analysis by Applications

      • 6.1 Global Natural Killer (NK) Cell Therapeutics Consumption Market Share by Application (2014-2019)
      • 6.2 Global Natural Killer (NK) Cell Therapeutics Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Natural Killer (NK) Cell Therapeutics Business

      • 7.1 Chipscreen Biosciences (China)
        • 7.1.1 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 7.1.2 Natural Killer (NK) Cell Therapeutics Product Introduction, Application and Specification
        • 7.1.3 Chipscreen Biosciences (China) Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Affimed NV (Netherlands)
        • 7.2.1 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 7.2.2 Natural Killer (NK) Cell Therapeutics Product Introduction, Application and Specification
        • 7.2.3 Affimed NV (Netherlands) Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Altor BioScience Corporation (USA)
        • 7.3.1 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 7.3.2 Natural Killer (NK) Cell Therapeutics Product Introduction, Application and Specification
        • 7.3.3 Altor BioScience Corporation (USA) Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Innate Pharma SA (France)
        • 7.4.1 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 7.4.2 Natural Killer (NK) Cell Therapeutics Product Introduction, Application and Specification
        • 7.4.3 Innate Pharma SA (France) Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Takeda Pharmaceutical (Japan)
        • 7.5.1 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 7.5.2 Natural Killer (NK) Cell Therapeutics Product Introduction, Application and Specification
        • 7.5.3 Takeda Pharmaceutical (Japan) Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Sorrento Therapeutics Inc. (USA)
        • 7.6.1 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 7.6.2 Natural Killer (NK) Cell Therapeutics Product Introduction, Application and Specification
        • 7.6.3 Sorrento Therapeutics Inc. (USA) Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 NantKwest Inc. (USA)
        • 7.7.1 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 7.7.2 Natural Killer (NK) Cell Therapeutics Product Introduction, Application and Specification
        • 7.7.3 NantKwest Inc. (USA) Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Bristol-Myers Squibb (USA)
        • 7.8.1 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 7.8.2 Natural Killer (NK) Cell Therapeutics Product Introduction, Application and Specification
        • 7.8.3 Bristol-Myers Squibb (USA) Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 NKT Therapeutics (USA)
        • 7.9.1 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Production Sites and Area Served
        • 7.9.2 Natural Killer (NK) Cell Therapeutics Product Introduction, Application and Specification
        • 7.9.3 NKT Therapeutics (USA) Natural Killer (NK) Cell Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served

      8 Natural Killer (NK) Cell Therapeutics Manufacturing Cost Analysis

      • 8.1 Natural Killer (NK) Cell Therapeutics Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Natural Killer (NK) Cell Therapeutics
      • 8.4 Natural Killer (NK) Cell Therapeutics Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Natural Killer (NK) Cell Therapeutics Distributors List
      • 9.3 Natural Killer (NK) Cell Therapeutics Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Natural Killer (NK) Cell Therapeutics Market Forecast

      • 11.1 Global Natural Killer (NK) Cell Therapeutics Production, Revenue Forecast
        • 11.1.1 Global Natural Killer (NK) Cell Therapeutics Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Natural Killer (NK) Cell Therapeutics Price and Trend Forecast (2019-2025)
      • 11.2 Global Natural Killer (NK) Cell Therapeutics Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Natural Killer (NK) Cell Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Natural Killer (NK) Cell Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Natural Killer (NK) Cell Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Natural Killer (NK) Cell Therapeutics Production, Revenue Forecast (2019-2025)
      • 11.3 Global Natural Killer (NK) Cell Therapeutics Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Natural Killer (NK) Cell Therapeutics Consumption Forecast (2019-2025)
        • 11.3.2 Europe Natural Killer (NK) Cell Therapeutics Consumption Forecast (2019-2025)
        • 11.3.3 China Natural Killer (NK) Cell Therapeutics Consumption Forecast (2019-2025)
        • 11.3.4 Japan Natural Killer (NK) Cell Therapeutics Consumption Forecast (2019-2025)
      • 11.4 Global Natural Killer (NK) Cell Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Natural Killer (NK) Cell Therapeutics Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Natural Killer (NK) Cell Therapeutics . Industry analysis & Market Report on Natural Killer (NK) Cell Therapeutics is a syndicated market report, published as Global Natural Killer (NK) Cell Therapeutics Market Research Report 2019. It is complete Research Study and Industry Analysis of Natural Killer (NK) Cell Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $4,350.00
        $5,800.00
        2,305.50
        3,458.25
        4,611.00
        2,682.50
        4,023.75
        5,365.00
        453,618.00
        680,427.00
        907,236.00
        242,237.00
        363,355.50
        484,474.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report